PharmaSynth AS
Active Registry code 11044101
AS Tartu linn Registered 29 Jun 2004
PharmaSynth AS is a AS based in Tartu linn, registry code 11044101, status: active. Main activity: Manufacture of basic pharmaceutical products. According to EMTA, turnover for Q3 2026 was €127 257 with 8 employees.
Turnover
127 257 €
↓ 36.0% vs Q2 2026
State taxes
39 503 €
↓ 2.3% vs Q2 2026
Labour taxes
42 807 €
↓ 0.0% vs Q2 2026
Employees
8
−1 vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 127 257 €above 37% of companiesindustry median 234 187 € · companies in the industry: 12
- Labour taxes per employee 5 351 €above 80% of companiesindustry median 4 573 € · companies in the industry: 12
- Revenue · 2025 896 270 €above 64% of companiesindustry median 48 003 € · companies in the industry: 19
- Net profit margin · 2025 26.3 %above 71% of companiesindustry median 9.8 % · companies in the industry: 15
Taxes and turnover
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 127 257 | 39 503 | 42 807 | 8 |
| Q2 2026 | 198 786 | 40 437 | 42 809 | 9 |
| Q1 2026 | 140 510 | 42 273 | 46 184 | 10 |
| Q4 2025 | 226 815 | 45 565 | 48 589 | 11 |
| Q3 2025 | 76 881 | 43 134 | 46 593 | 11 |
| Q2 2025 | 205 836 | 37 212 | 39 265 | 10 |
| Q1 2025 | 231 372 | 44 449 | 47 436 | 9 |
| Q4 2024 | 144 888 | 39 879 | 42 231 | 9 |
| Q3 2024 | 188 774 | 34 016 | 35 984 | 9 |
| Q2 2024 | 105 109 | 33 098 | 35 258 | 8 |
| Q1 2024 | 139 707 | 31 248 | 32 989 | 8 |
| Q4 2023 | 102 827 | 30 656 | 32 096 | 8 |
| Q3 2023 | 189 320 | 30 191 | 31 857 | 8 |
| Q2 2023 | 144 998 | 34 125 | 36 061 | 8 |
| Q1 2023 | 194 811 | 30 068 | 31 743 | 8 |
| Q4 2022 | 139 706 | 24 295 | 25 556 | 8 |
| Q3 2022 | 108 932 | 19 036 | 19 929 | 8 |
| Q2 2022 | 113 668 | 16 704 | 15 588 | 8 |
| Q1 2022 | 124 229 | 19 012 | 20 015 | 7 |
Labour taxes per employee per month
1 784 €
Turnover per employee in the quarter
15 907 €
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 896 270 | 236 116 | 422 547 | 1 368 917 | 1 284 508 | 9 |
| 2024 | 586 714 | 152 148 | 373 405 | 1 123 717 | 1 048 392 | 8 |
| 2023 | 635 352 | 145 484 | 297 674 | 940 779 | 896 244 | 7 |
| 2022 | 475 618 | 121 436 | 222 785 | 833 351 | 750 760 | 7 |
| 2021 | 510 772 | 247 819 | 176 627 | 679 080 | 629 324 | 7 |
| 2020 | 444 406 | 199 141 | 156 011 | 437 233 | 381 505 | 7 |
| 2019 | 311 800 | 42 880 | 180 026 | 239 082 | 182 364 | 8 |
| 2018 | — | — | — | — | — | 9 |
| 2017 | — | — | — | — | — | 8 |
| 2016 | — | — | — | — | — | 7 |
| 2015 | — | — | — | — | — | 7 |
| 2014 | — | — | — | — | — | 7 |
| 2013 | — | — | — | — | — | 7 |
| 2012 | — | — | — | — | — | 8 |
| 2011 | — | — | — | — | — | 5 |
| 2010 | — | — | — | — | — | 5 |
| 2009 | — | — | — | — | — | 4 |
| 2008 | — | — | — | — | — | 5 |
| 2007 | — | — | — | — | — | 5 |
| 2006 | — | — | — | — | — | 3 |
| 2005 | — | — | — | — | — | 4 |
| 2004 | — | — | — | — | — | 2 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Net profit margin
26.3 %
Net profit / revenue
Return on equity (ROE)
18.4 %
Net profit / equity
Return on assets (ROA)
17.2 %
Net profit / assets
Equity ratio
93.8 %
Equity / assets
Debt ratio
6.2 %
Liabilities / assets
Current ratio
14.02
Current assets / current liabilities
Revenue per employee
99 586 €
Revenue / average full-time employees
Labour cost per employee per month
3 912 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 29 Jun 2026 | Company’s own · audited | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 30 Jun 2025 | Company’s own · audited | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 26 Jun 2024 | Company’s own · audited | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 21 Jun 2023 | Company’s own · audited | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 2 Mar 2023 | Company’s own · audited | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 5 Aug 2021 | Company’s own · audited | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 5 Oct 2020 | Company’s own · audited | e-Äriregister |
Board
- Nasdaq CSD SEKeeper of the share ledger · since 28 Sep 2017
- Pirkko Irene Penttilä-HiltunenBoard member · since 17 Oct 2022
Right of representation
Any member of the management board may represent the public limited company in all transactions.
Owners
No owner information.
Beneficial owners
- Pirkko Irene Penttilä-HiltunenDirect ownership · FIN · since 26 Oct 2026
Founders and other persons
- Christer HalldinFounder · 78 000 € · 2 Apr 2004
- Heli Väärtnõu-JärvFounder · 15 000 € · 2 Apr 2004
- Jaak JärvFounder · 15 000 € · 2 Apr 2004
- Jukka Veli HiltunenFounder · 234 000 € · 2 Apr 2004
- Pirkko Irene Penttilä-HiltunenFounder · 32 000 € · 2 Apr 2004
- Sari Anneli HalldinFounder · 32 000 € · 2 Apr 2004
- OÜ EDUSOFTFounder · 78 000 € · 2 Apr 2004
- SILLAMATSI MEDICAL OÜFounder · 469 000 € · 2 Apr 2004
- Maarika MägiAudit firm · 1 Jan 2009
- Fiducia Audit OÜAudit firm · 1 Jan 2009
- Jaak JärvChairman of the supervisory board · 10 Oct 2022
- Heli Väärtnõu-JärvSupervisory board member · 10 Oct 2022
- Olavi LoogSupervisory board member · 10 Oct 2022
- Omanikukonto: NARD INSTITUTE LTDShareholder · 6 600 € · 16 Aug 2023
- Omanikukonto: SILLAMATSI MEDICAL OÜShareholder · 28 140 € · 16 Aug 2023
- Omanikukonto: JUKKA VELI HILTUNENShareholder · 14 040 € · 23 Sep 2025
- Omanikukonto: HELI VÄÄRTNÕU-JÄRVShareholder · 6 180 € · 5 Dec 2025
Related companies
Activities (EMTAK)
- 21101Manufacture of basic pharmaceutical products Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 20027113 / 12 19 Jul 2023 |
Amendment entry | In force 19 Jul 2023 |
||
| Ä 20027113 / 11 2 Mar 2023 |
Amendment entry | In force 2 Mar 2023 |
||
| Ä 20027113 / 10 17 Oct 2022 |
Amendment entry | In force 17 Oct 2022 |
||
| Ä 20027113 / 9 29 Jul 2022 |
Entry made by the register on its own initiative | In force 29 Jul 2022 |
||
| Ä 20027113 / M5 15 Jun 2022 |
Ruling to eliminate deficiencies | 13 Sep 2022 | Deficiencies eliminated 10 Oct 2022 |
|
| Ä 20027113 / 8 22 Feb 2019 |
Amendment under Commercial Code § 525 (2) | In force 22 Feb 2019 |
||
| Ä 20027113 / M4 13 Sep 2018 |
Warning of deletion published in Ametlikud Teadaanded | In force 13 Sep 2018 |
||
| Ä 20027113 / M3 9 Mar 2018 |
Warning of deletion from the register: annual report not filed | 10 Sep 2018 | Deficiencies eliminated 25 Sep 2018 |
|
| Ä 20027113 / 7 18 Jan 2018 |
Amendment entry | In force 18 Jan 2018 |
||
| Ä 20027113 / 6 23 Dec 2017 |
Amendment entry | In force 23 Dec 2017 |
||
| Ä 20027113 / 5 3 Dec 2017 |
Amendment entry | In force 3 Dec 2017 |
||
| Ä 20027113 / 4 28 Sep 2017 |
Amendment entry | In force 28 Sep 2017 |
||
| Ä 20027113 / 3 10 May 2017 |
Amendment entry | In force 10 May 2017 |
||
| Ä 27113 / 2 3 Dec 2008 |
Deletion of activities from the registry card | In force 3 Dec 2008 |
||
| Ä 27113 / M2 30 Nov 2006 |
Warning of a fine: deficiencies in the annual report | 17 Jan 2007 | Deficiencies eliminated 1 Dec 2006 |
|
| Ä 27113 / M1 10 Oct 2006 |
Warning of a fine: annual report not filed | 30 Oct 2006 | Deficiencies eliminated 3 Jan 2007 |
|
| Ä 27113 28 Jun 2004 |
First entry | In force |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data